Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

RELEASE DATE
19-Dec-2022
REGION
North America
Deliverable Type
Market Outlook
Research Code: MGMF-01-00-00-00
SKU: HC03618-NA-MO_27285
AvailableYesPDF Download

$2,450.00

Special Price $2,205.00 save 10 %

In stock
SKU
HC03618-NA-MO_27285

$2,450.00

$2,205.00save 10 %

DownloadLink
ENQUIRE NOW

Description


An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. With the onset of the COVID-19 pandemic, the rate of industry transformation has only accelerated.

In addition, the COVID-19 pandemic has underscored the need for equanimity in access to diagnostics and renewed focus on direct-to-patient, decentralized diagnostics products as well as digital continuity, all of which center the patient. Another aspect changing the diagnostics industry is linking automation to digital technologies for improved efficiency and productivity.

As we approach 2023, a shift towards contract research, development, and manufacturing organization (CRDMO) business models is driving growth in pharma contract services. Also, the impact of geopolitical chaos and competitive intensity is creating growth opportunities in drug discovery and pre-clinical services, bio-processing, and agile partnership models.

Frost & Sullivan research addresses the internal challenges and industry convergence happening in the life sciences industry and enabled by digital therapeutics, novel diagnostics technologies, real-world evidence solutions, clinical trials data management services, and AI-driven platforms to enhance workflow and accuracy. In this Outlook, Frost & Sullivan identifies the 10 top growth opportunities for the global life sciences industry in 2023.

Table of Contents

Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

  • Top 10 for 2023: Growth Opportunities for the Life Sciences Industry
An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. With the onset of the COVID-19 pandemic, the rate of industry transformation has only accelerated. In addition, the COVID-19 pandemic has underscored the need for equanimity in access to diagnostics and renewed focus on direct-to-patient, decentralized diagnostics products as well as digital continuity, all of which center the patient. Another aspect changing the diagnostics industry is linking automation to digital technologies for improved efficiency and productivity. As we approach 2023, a shift towards contract research, development, and manufacturing organization (CRDMO) business models is driving growth in pharma contract services. Also, the impact of geopolitical chaos and competitive intensity is creating growth opportunities in drug discovery and pre-clinical services, bio-processing, and agile partnership models. Frost & Sullivan research addresses the internal challenges and industry convergence happening in the life sciences industry and enabled by digital therapeutics, novel diagnostics technologies, real-world evidence solutions, clinical trials data management services, and AI-driven platforms to enhance workflow and accuracy. In this Outlook, Frost & Sullivan identifies the 10 top growth opportunities for the global life sciences industry in 2023.
More Information
Deliverable Type Market Outlook
Author Piyush Bansal
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Life Sciences Industry Trends
Keyword 2 Life Sciences Industry Growth
Keyword 3 life sciences industry
Podcast No
Predecessor M2DB-01-00-00-00
WIP Number MGMF-01-00-00-00